Comparison between different first-line therapy protocols in eradicating Helicobacter pylori in a region with high clarithromycin resistance

Yilmaz B., Koseoglu H., Coskun Y., Deveci M., Kekilli M.

GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, cilt.13, sa.2, ss.150-156, 2018 (ESCI, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5114/pg.2018.72732
  • Dergi Adı: GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.150-156
  • Anahtar Kelimeler: Helicobacter pylori eradication, clarithromycin resistance, STANDARD TRIPLE THERAPY, SEQUENTIAL THERAPY, ANTIBIOTIC-RESISTANCE, QUADRUPLE THERAPY, INFECTION, BISMUTH, MANAGEMENT, EFFICACY, TRIAL, AMOXICILLIN
  • Gazi Üniversitesi Adresli: Hayır

Özet

Introduction: Helicobacter pylori infection is encountered in more than 50% of the world population. A high rate of clarithromycin resistance is observed among Helicobacter pylori strains in some regions because clarithromycin is a drug commonly used for the treatment of other infections.